Manganese neurotoxicity: Connecting the dots along the continuum of dysfunction

NeuroToxicology

Volumn 27, Issue 3, 2006, Pages 347-349

  Martin, Christopher J ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Manganese; Manganism; Neurotoxicity

Indexed keywords

DOPAMINE; FLUORODOPA F 18; MANGANESE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL FEATURE; ENVIRONMENTAL EXPOSURE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; IDIOPATHIC DISEASE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

HUMANS; MANGANESE POISONING; NEUROTOXICITY SYNDROMES; PARKINSON DISEASE; WELDING;

EID: 33646493798     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2005.11.002     Document Type: Article

References (15)

1. Calne D.B., de la Fuente-Fernandez R., and Kishore A. Contributions of positron emission tomography to elucidating the pathogenesis of idiopathic parkinsonism and dopa responsive dystonia. J Neural Transm Suppl 50 (1997) 47-52
2. Couper J. On the effects of black oxide of manganese when inhaled into the lungs. Br Ann Med Pharmacol 1 (1837) 41-42
3. Huang C.C., Chu N.S., Lu C.S., Chen R.S., and Calne D.B. Long-term progression in chronic manganism. Ten years of follow-up. Neurology 50 (1998) 698-700
4. Iregren A. Manganese neurotoxicity in industrial exposures: proof of effects, critical exposure level, and sensitive tests. Neurotoxicology 20 (1999) 315-324
5. Kim Y., Kim K.S., Yang J.S., Park I.J., Kim E., Jin Y., et al. Increase in signal intensities on T1-weighted magnetic resonance images in asymptomatic manganese-exposed workers. Neurotoxicology 20 6 (1999) 901-907
6. Mergler D., Baldwin M., Belanger S., Larribe F., Beuter A., Bowler R., et al. Manganese neurotoxicity, a continuum of dysfunction: results from a community based study. Neurotoxicology 20 2-3 (1999) 327-342
7. Myers J.E., Thompson M.L., Ramushu S., Young T., Jeebhay M.F., London L., et al. The nervous system effects of occupational exposure on workers in a South African manganese smelter. Neurotoxicology 24 6 (2003) 885-894
8. Nelson K., Golnick J., Korn T., and Angle C. Manganese encephalopathy: utility of early magnetic resonance imaging. Br J Ind Med 50 6 (1993) 510-513
9. Racette B.A., McGee-Minnich L., Moerlein S.M., Mink J.W., Videen T.O., and Perlmutter J.S. Welding related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 56 (2001) 8-13
10. Roels H.A., Ortega Eslava M.I., Ceulemans E., Robert A., and Lison D. Prospective study on the reversibility of neurobehavioral effects in workers exposed to manganese dioxide. Neurotoxicology 20 (1999) 255-272
11. Schuler P., Oyanguren H., Maturana V., Valenzuela A., Cruz E., Plaza V., et al. Manganese poisoning: environmental and medical study at a Chilean mine. Ind Med Surg 26 (1957) 167-173
12. Shinotoh H., Snow B.J., Hewitt K.A., Pate B.D., Doudet D., Nugent R., et al. MRI and PET studies of manganese-intoxicated monkeys. Neurology 45 6 (1995) 1199-1204
13. Vingerhoets F.J., Snow B.J., Tetrud J.W., Langston J.W., Schulzer M., and Calne D.B. Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol 36 5 (1994) 765-770
14. Wang J.-D., Huang C.-C., Hwang Y.-H., Chiang J.R., Lin J.M., and Chen J.S. Manganese induced parkinsonism: an outbreak due to an unrepaired ventilation control system in a ferromanganese smelter. Br J Ind Med 46 (1989) 856-859
15. Welch L.S., Rappaport S.M., and Susi P. Construction welding exposures to manganese likely to exceed proposed TLV. J Occup Environ Hyg 1 6 (2004) D63-D65